Innovative Sensor Technology
EnteraSense has developed an innovative sensor technology to detect and monitor Upper Gastrointestinal Bleeding (UGIB).
Welcome to EnteraSense
Innovative Sensor Technology
EnteraSense has developed an innovative sensor technology to detect and monitor Upper Gastrointestinal Bleeding (UGIB).
Improving Patient Outcomes
EnteraSense Limited is a medical device sensor diagnostic company founded in 2015 by Donal Devery, Dr. Marvin Ryou and Dr. Chris Thompson of Brigham and Women’s Hospital/Harvard Medical School in the United States.
Where are we
Based in Galway, Ireland we have a licensed technology agreement from Brigham and Women’s Hospital/Harvard Medical School which enables us to develop ground-breaking devices for diagnosing and monitoring Upper Gastric Bleeds.
Meet The Team
Based in Galway, Ireland we have a licensed technology agreement from Brigham and Women’s Hospital/Harvard Medical School which enables us to develop ground-breaking devices for diagnosing and monitoring Upper Gastric Bleeds.
Get In Touch. We are always open to talk more about our product, healthcare and the marketplace.
EnteraSense is developing an innovative sensor technology to detect and monitor Upper Gastrointestinal Bleeding (UGIB). The company has licensed the technology from Brigham and Women’s Hospital and Harvard Medical School and has augmented the Intellectual Property portfolio with further development of the technology.
Based in Galway, Ireland we have a licensed technology agreement from Brigham and Women’s Hospital/Harvard Medical School which enables us to develop ground-breaking devices for diagnosing and monitoring Upper Gastric Bleeds.
Location: Block 4, Ballybrit Business Park, Galway, H91 A4XW
